Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2C-G-N

From Wikipedia, the free encyclopedia
Pharmaceutical compound
2C-G-N
Clinical data
Other names2C-G-NPH; 2C-NPH; 1,4-Dimethoxynaphthyl-2-ethylamine
Routes of
administration
Oral[1]
Drug classPsychoactive drug;Stimulant;Antidepressant
ATC code
  • None
Pharmacokinetic data
Duration of action20–30 hours[1]
Identifiers
  • 2-(1,4-dimethoxynaphthalen-2-yl)ethanamine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC14H17NO2
Molar mass231.295 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C2=CC=CC=C21)OC)CCN
  • InChI=1S/C14H17NO2/c1-16-13-9-10(7-8-15)14(17-2)12-6-4-3-5-11(12)13/h3-6,9H,7-8,15H2,1-2H3
  • Key:VKWQEEWEGKDTDE-UHFFFAOYSA-N

2C-G-N, or2C-G-NPH, also known as1,4-dimethoxynaphthyl-2-ethylamine, is apsychoactive drug of thephenethylamine,2C, andnaphthylethylamine families.[1] It is thederivative of2C-G in which the 3,4-dimethyl groups have been extended and connected to form a secondbenzenering and hence has a2-naphthalenering system.[1] In his bookPiHKAL (Phenethylamines I Have Known and Loved) and other publications,Alexander Shulgin lists 2C-G-N's dose as 20 to 40 mgorally and itsduration as 20 to 30 hours.[1][2][3] The effects of the drug were reported to include someamphetamine-likestimulation, some possibleantidepressant-like effects, "not muchpsychedelic" but "something really going on anyway", faint uneasiness, and "not as friendly" of effects as other 2C-G compounds.[1] Its activity was described as "on the wane" compared to other 2C-G drugs and as lasting "too long".[1] Thechemical synthesis of 2C-G-N has been described.[1] The drug was first described in the literature by Shulgin inPiHKAL in 1991.[1]

See also

[edit]

References

[edit]
  1. ^abcdefghiShulgin, Alexander;Shulgin, Ann (September 1991).PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press.ISBN 0-9630096-0-5.OCLC 25627628.https://www.erowid.org/library/books_online/pihkal/pihkal031.shtml
  2. ^Jacob P, Shulgin AT (1994)."Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs". In Lin GC, Glennon RA (eds.).Hallucinogens: An Update(PDF). National Institute on Drug Abuse Research Monograph Series. Vol. 146. National Institute on Drug Abuse. pp. 74–91.PMID 8742795. Archived fromthe original on 13 July 2025.
  3. ^Shulgin AT (2003)."Basic Pharmacology and Effects". In Laing RR (ed.).Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137.ISBN 978-0-12-433951-4. Archived fromthe original on 13 July 2025.

External links

[edit]
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-G-N&oldid=1323690598"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp